Michael Kelly

Michael Kelly

Chief Executive Officer at NERVGEN PHARMA CORP.

Net worth: 889 226 $ as of 30/04/2024

59 year
Health Technology
Consumer Services

Profile

Mr. Michael Kelly is a President, Chief Executive Officer & Director at NervGen Pharma Corp.
and an Independent Director at ARS Pharmaceuticals, Inc. He is on the Board of Directors at NervGen Pharma Corp., ARS Pharmaceuticals Operations, Inc. and ARS Pharmaceuticals, Inc. Mr. Kelly was previously employed as a President-US Operations by Adapt Pharma, Inc., a President by Covis Pharmaceuticals, Inc., a Senior Vice President-Sales & Marketing by Jazz Pharmaceuticals Plc, a Senior Vice President & General Manager by Azur Pharma, Inc., a Member by Azur Pharma Ltd., a Vice President-Commercial Operations by Guilford Pharmaceuticals, Inc., and a Vice President-Sales and Marketing by Viropharma, Inc. He received his undergraduate degree from The College of New Jersey and an MBA from Rider University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/03/2024 83,225 ( 0.09% ) 673 290 $ 30/04/2024
28/03/2024 143,957 ( 0.24% ) 215 936 $ 30/04/2024

Michael Kelly active positions

CompaniesPositionStart
ARS PHARMACEUTICALS, INC. Director/Board Member 01/05/2019
NERVGEN PHARMA CORP. Chief Executive Officer 10/04/2023
Director/Board Member 01/05/2019
All active positions of Michael Kelly

Former positions of Michael Kelly

CompaniesPositionEnd
Chief Operating Officer 01/06/2019
Chief Executive Officer 01/03/2016
Corporate Officer/Principal 27/01/2012
Corporate Officer/Principal 01/01/2012
Chief Operating Officer 03/10/2005
See the detail of Michael Kelly's experience

Training of Michael Kelly

The College of New Jersey Undergraduate Degree
Rider University Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Kelly's experience

Connections

40

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
JAZZ PHARMACEUTICALS PLC

Health Technology

NERVGEN PHARMA CORP.

Health Technology

ARS PHARMACEUTICALS, INC.

Health Technology

Private companies7

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Viropharma, Inc.

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW